HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Donald L Morton Selected Research
Donald L Morton Research Topics
Disease
86
Melanoma (Melanoma, Malignant)
12/2017 - 03/2002
55
Neoplasms (Cancer)
01/2016 - 03/2002
41
Neoplasm Metastasis (Metastasis)
12/2017 - 03/2002
9
Colorectal Neoplasms (Colorectal Cancer)
07/2006 - 01/2002
8
Neoplasm Micrometastasis
01/2011 - 05/2002
4
Circulating Neoplastic Cells
11/2012 - 02/2006
3
Lymphatic Metastasis
11/2012 - 12/2002
3
Colonic Neoplasms (Colon Cancer)
10/2007 - 07/2002
3
Prostatic Neoplasms (Prostate Cancer)
09/2005 - 11/2004
2
Necrosis
10/2009 - 08/2002
2
Hypersensitivity (Allergy)
12/2002 - 08/2002
1
Bites and Stings (Sting)
10/2011
1
Cutaneous Malignant Melanoma
01/2010
1
Infections
09/2007
1
Communicable Diseases (Infectious Diseases)
09/2007
Drug/Important Bio-Agent (IBA)
19
Vaccines
IBA
12/2017 - 06/2002
17
Antigens
IBA
04/2009 - 03/2002
15
Biomarkers (Surrogate Marker)
IBA
06/2014 - 01/2002
13
Proteins (Proteins, Gene)
FDA Link
01/2016 - 12/2002
10
Messenger RNA (mRNA)
IBA
01/2016 - 12/2002
10
Gangliosides
IBA
06/2014 - 01/2002
10
Canvaxin
IBA
02/2012 - 08/2002
9
Cancer Vaccines
IBA
09/2007 - 12/2002
8
Antibodies
IBA
06/2014 - 08/2002
8
Paraffin
IBA
06/2012 - 10/2003
8
Immunoglobulin M (IgM)
IBA
06/2007 - 08/2002
7
RNA-Directed DNA Polymerase (Reverse Transcriptase)
IBA
11/2012 - 12/2002
5
polyvalent melanoma cell vaccine
IBA
10/2004 - 06/2002
4
HMW-MAA
IBA
10/2011 - 06/2008
4
RNA (Ribonucleic Acid)
IBA
11/2008 - 01/2005
3
Ipilimumab
IBA
01/2014 - 03/2012
3
Monoclonal Antibodies
IBA
01/2014 - 02/2004
3
Glycoproteins (Glycoprotein)
IBA
08/2013 - 08/2002
3
Soil
IBA
06/2012 - 06/2008
3
DNA (Deoxyribonucleic Acid)
IBA
03/2011 - 03/2004
3
Hematoxylin (Haematoxylon)
IBA
10/2007 - 05/2002
3
Eosine Yellowish-(YS) (Eosin)
IBA
10/2007 - 05/2002
3
Tumor Biomarkers (Tumor Markers)
IBA
08/2007 - 12/2002
3
Cytokines
IBA
06/2007 - 09/2002
3
Combined Vaccines
IBA
12/2005 - 08/2002
3
Complement System Proteins (Complement)
IBA
06/2005 - 12/2003
3
Monophenol Monooxygenase (Tyrosinase)
IBA
10/2003 - 01/2003
2
Indicators and Reagents (Reagents)
IBA
10/2012 - 09/2005
2
Vemurafenib
IBA
07/2012 - 03/2012
2
Biological Products
IBA
05/2011 - 09/2002
2
L-Lactate Dehydrogenase (Lactate Dehydrogenase)
IBA
12/2009 - 05/2004
2
Small Interfering RNA (siRNA)
IBA
02/2008 - 09/2004
2
Complementary DNA (cDNA)
IBA
07/2006 - 09/2004
2
Ligands
IBA
07/2006 - 09/2004
2
MART-1 Antigen
IBA
07/2004 - 01/2003
2
Enzymes
IBA
01/2004 - 10/2003
2
Fluorouracil (Carac)
FDA Link
Generic
10/2003 - 03/2002
2
Coloring Agents (Dyes)
IBA
10/2003 - 03/2003
2
Calcibiotic Root Canal Sealer
IBA
02/2003 - 12/2002
2
Antigen-Antibody Complex (Immune Complex)
IBA
03/2002 - 03/2002
1
Membrane Glycoproteins (Membrane Glycoprotein)
IBA
01/2015
1
RNA Splicing Factors
IBA
01/2015
1
Transient Receptor Potential Channels
IBA
06/2014
1
Metalloproteases (Metalloproteinases)
IBA
06/2014
1
CTLA-4 Antigen
IBA
01/2014
1
obatoclax
IBA
03/2013
1
Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)
IBA
03/2013
1
Pharmaceutical Preparations
IBA
03/2013
1
Imiquimod (Aldara)
FDA Link
Generic
11/2012
1
Nucleotides
IBA
06/2012
1
Interleukin-2 (IL2)
IBA
10/2011
1
Bispecific Antibodies
IBA
10/2011
1
Surface Antigens (Surface Antigen)
IBA
10/2011
1
Chondroitin Sulfate Proteoglycans
IBA
10/2011
1
Protein Isoforms (Isoforms)
IBA
03/2011
1
tissue-factor-pathway inhibitor 2 (PP5)
IBA
03/2011
1
Methyltransferases
IBA
03/2011
1
Fatty Acids (Saturated Fatty Acids)
IBA
01/2010
1
Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
IBA
11/2009
1
Glucose (Dextrose)
FDA Link
Generic
10/2009
1
Caspase 3 (Caspase-3)
IBA
10/2009
1
Biological Factors
IBA
10/2009
1
Mutant Proteins (Protein, Mutant)
IBA
04/2009
1
SDM
IBA
03/2009
1
NF-kappa B (NF-kB)
IBA
11/2008
1
Toll-Like Receptors (Toll-Like Receptor)
IBA
11/2008
1
Chemokines
IBA
02/2008
1
Integrins
IBA
02/2008
1
Interleukin-10 (Interleukin 10)
IBA
11/2007
1
Autoantigens
IBA
09/2007
1
Neoplasm Antigens (Tumor Antigens)
IBA
09/2007
1
Interleukin-13
IBA
06/2007
1
Leptin
IBA
06/2007
Therapy/Procedure
31
Lymph Node Excision (Lymph Node Dissection)
02/2014 - 03/2002
22
Immunotherapy
12/2017 - 06/2002
22
Therapeutics
12/2017 - 03/2002
6
Metastasectomy
12/2017 - 05/2006
4
Drug Therapy (Chemotherapy)
03/2004 - 04/2003
3
Cytoreduction Surgical Procedures
12/2005 - 12/2002
2
Biological Therapy
03/2012 - 02/2004
2
Radiotherapy
03/2004 - 02/2004
1
Precision Medicine
01/2015
1
Thoracotomy
09/2012
1
Length of Stay
12/2010
1
Proctectomy
01/2010